CorMedix Inc.

6.08
-0.08 (-1.30%)
At close: Apr 01, 2025, 3:59 PM
6.05
-0.47%
After-hours: Apr 01, 2025, 07:59 PM EDT

CorMedix Cash Flow Statement

Year FY24 FY23 FY22 FY21 FY20
Net Income -17.93B -46.34M -29.7M -28.21M -22.03M
Depreciation & Amortization 309.78K 70.75K 84.62K 61.89K 127.96K
Stock-Based Compensation 6.13B 5.49M 4.07M 5.04M 2.5M
Other Working Capital 59.8B 2.23M 1.03M 651.87K -2.88M
Other Non-Cash Items -38.77B 134.81K 124.42K 7.06M 60.05K
Deferred Income Tax n/a n/a n/a -6.94M -516
Change in Working Capital -39.41M 2.23M 1.07M 1.84M -2.63M
Operating Cash Flow -50.61B -38.41M -24.36M -21.16M -21.97M
Capital Expenditures n/a -327.3K -219.36K -1.43M -112.64K
Acquisitions n/a n/a 3.71M 9.13M -7.54M
Purchase of Investments -26.77B -77.08M -31.14M -15.29M -8.55M
Sales Maturities Of Investments 48.12B 60.35M 27.65M 7.58M 16.09M
Other Investing Acitivies -115.73M n/a -3.71M -9.13M 7.54M
Investing Cash Flow 21.23B -17.06M -3.71M -9.13M 7.43M
Debt Repayment n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a
Other Financial Acitivies 26.3B 89.3K 128.63K 301.92K 411.75K
Financial Cash Flow 26.32B 55.92M 17.9M 41.76M 40.1M
Net Cash Flow -3.07B 448.45K -10.18M 11.45M 25.57M
Free Cash Flow -50.61B -38.74M -24.58M -22.58M -22.08M